Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Lines up ViraCor as First RVP Dx Provider

NEW YORK (GenomeWeb News) – A day after Luminex’s respiratory viral panel got the nod from the US Food and Drug Administration, the company signed up ViraCor Laboratories as the first national reference lab to offer the test, ViraCor said today.
 
As GenomeWeb Daily News reported Thursday, Luminex’s xTAG RVP detects 12 major respiratory viruses and subtypes from one sample, including adenovirus, three strains of influenza A, rhinovirus, and others.
 
The panel’s sensitivity and specificity “helps eliminate incorrect diagnosis by greatly reducing false negative results that are common with conventional testing methods,” said ViraCor VP and CSO Steve Kleiboeker.
 
Viacor noted that it offers a 24-hour turnaround time on tests.
 
Financial terms of the agreement were not released.
The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.